U.S. Physical Therapy, Inc. (USPH) Q1 2026 Earnings Call Summary

1Key Financial Results and Metrics

Total Revenue: $198 million, a 7.9% increase year-over-year.

Physical Therapy Revenue: $168 million, up 7.2% from Q1 2025.

Daily Visits per Clinic: Increased to 31.8 from 31.2 in Q1 2025.

Total Patient Visits: 1.543 million, a 6.9% increase year-over-year.

Net Patient Revenue per Visit: $106.49, up from $105.66 in the prior year.

Adjusted EBITDA: $20.2 million, a $700,000 increase from Q1 2025.

Net Income: $5 million, down from $9.9 million in Q1 2025.

GAAP Loss per Share: $0.12, compared to earnings of $0.80 in Q1 2025.

Adjusted Physical Therapy Margin: Decreased to 16.1% from 16.8% in Q1 2025.

Interest Expense: Increased to $2.8 million from $2.3 million in Q1 2025.

2Strategic Updates and Business Highlights

Key Initiatives:

Semi-virtualization of front desk operations to enhance efficiency.

Implementation of AI-assisted documentation technology.

Reengagement with remote therapeutic monitoring for Medicare patients.

Expansion of cash-based programs in top partnerships.

Development of partnerships with large hospital systems, including NYU.

Acquisitions: Completed two significant acquisitions in January, enhancing revenue streams.

Credit Facility: Secured a new five-year $450 million credit facility, improving terms and expanding capacity for growth investments.

3Forward Guidance and Outlook

2026 Guidance: Reaffirmed full-year adjusted EBITDA guidance of $102 million to $106 million.

Growth Confidence: Management expressed confidence in achieving growth targets due to strong demand and the ramp-up of strategic initiatives.

4Bad News, Challenges, or Points of Concern

Weather Impact: Lost over 31,000 visits due to adverse weather conditions, resulting in an estimated revenue loss of $3.3 million and margin drag due to fixed salary obligations.

Declining Metrics: Adjusted Physical Therapy margin decreased and net income fell significantly compared to the previous year.

Medicaid Rate Drop: Noted a small decline in Medicaid rates, which could impact future revenue.

Rising Costs: Increased operating costs per visit and corporate expenses, attributed to weather impacts and upfront investments in strategic initiatives.

5Notable Q&A Insights

Quarterly Performance: Management confirmed Q1 results aligned with budget expectations despite weather-related disruptions.

Hospital Partnerships: Potential for larger hospital partnerships exists, with ongoing discussions indicating a robust pipeline.

Cost Management: Anticipated reduction in operating costs per visit as weather impacts subside and volumes normalize.

Cash-Based Programs: Strong traction in cash-based services like laser therapy and dry needling, with partners reporting significant revenue generation from these initiatives. Overall, while USPH demonstrated solid revenue growth and reaffirmed its guidance, challenges such as weather impacts, declining margins, and rising costs present notable headwinds that management is actively addressing.